Business, energy, technology, markets and global industry news from Business News Today

shingles vaccine

PharmaDeviceNews shingles vaccine
Representative image of next-generation vaccine research, showing how AAHI’s SLA-SE adjuvant technology is gaining attention through Eli Lilly and Company’s acquisition of Curevo Vaccine and its shingles vaccine candidate amezosvatein.
Pharma & Biotech

Lilly’s Curevo deal turns AAHI’s adjuvant science into a late-stage vaccine opportunity

Find out how AAHI’s SLA-SE adjuvant could shape Lilly’s next-generation shingles vaccine strategy after the Curevo acquisition.

Read More
Representative image of adult hepatitis B and shingles vaccines, aligned with Sanofi’s acquisition of Dynavax and its push into global adult immunization markets.
Pharma & Biotech

Why Sanofi’s $2.2bn Dynavax deal is a high-stakes bet on adult vaccines

Sanofi to acquire Dynavax for $2.2B to boost adult vaccines. Find out how HEPLISAV-B and Z-1018 fit into Sanofi’s global immunization strategy.

Read More